#hepatitisD
LightNews LightNews
shihcheng.bsky.social
In a phase 2b trial, 180 patients were assigned to receive peginterferon alone or combined with bulevirtide for chronic hepatitis D. Combo therapy showed promise for finite treatment. #HepatitisD #clinicaltrials PMID:38842520, N Engl J Med 2024
buff.ly
December 31, 2024 at 4:00 PM
d-solve-consortium.bsky.social
🧬 Join the HBV Community Forum & Int. HBV Meeting in Berlin (Sept 8–12), on-site or online!
🎤 Science meets community – Hepatitis B & D!
D-SOLVE’s Heiner Wedemeyer & Helenie Kefalakes will be there.
👉 www.hbvmeeting.org
#HBVForum2025 #HepatitisB #HepatitisD
Flyer International HBV Meeting 8-12 Sept 2025 Berlin
September 2, 2025 at 10:57 AM
thervacb-eu.bsky.social
💡 Looking for trusted info on #HepatitisB & #HepatitisD?

The #TherVacB & #DSOLVE video campaign “Insights on #HDV & #HBV” explains co-infection, diagnosis & treatment in expert-led, patient-focused videos⚕️

📺 Explore the full resource: tinyurl.com/HepatitisBDInsights

#WHD2025 #LiverSky
World Hepatitis Day 2025 with Ongoing Awareness Campaign “Insights on HDV and HBV”
Stay informed, stay protected with our campaign “Insights on HDV and HBV” – everything you need to know about hepatitis D and B.
tinyurl.com
July 25, 2025 at 10:23 AM
thervacb-eu.bsky.social
💡 Sie suchen fundierte Informationen zu #HepatitisB & #HepatitisD?
Die Kampagne „Aufklärung zu #HDV & #HBV“ von #TherVacB & #DSOLVE erklärt Co-Infektion, Diagnose und Therapie in Videos mit Expertinnen & Patientenperspektiven⚕️

📺 Zur Videoreihe: tinyurl.com/HepatitisBDW...

#WHT2025 #HepSky
TherVacB & D-Solve unterstützen den Welt-Hepatitis-Tag 2025 mit ihrer Kampagne „Aufklärung über HDV und HBV“
Gut informiert, besser geschützt mit unserer Kampagne „Aufklärung über HDV und HBV“ - alles, was Sie über Hepatitis D und B wissen sollten
tinyurl.com
July 25, 2025 at 1:22 PM
iamydb.bsky.social
#HepatitisD carcinogenic
who.int WHO @who.int · Jul 28
#Hepatitis update you should know:

The International Agency for Research on Cancer (IARC) has now classified hepatitis D as carcinogenic to humans, just like hepatitis B & C.

⚠️ It causes liver cancer & only spreads in people already infected with hepatitis B.

Learn more 👉 bit.ly/4mjGQCY
A text box reads: “Hepatitis D is now classified as carcinogenic to humans, just like hepatitis B and C.” Below, a note says: “It causes liver cancer and can only spread in people already infected with hepatitis B.”
July 28, 2025 at 6:23 PM
d-solve-consortium.bsky.social
🎙️ Live now! Prof. Eui-Cheol Shin (KAIST, Korea) is presenting “Cytokine-induced bystander CD8+ T cell activation and its regulation in viral hepatitis” – part of our Translational Seminar Series.
Join the discussion live 👉 msteams.link/DGTP
#HepatitisD #D-SOLVE #HaDEA #EUHealth
December 8, 2025 at 4:07 PM
thebinderlab.bsky.social
Infos zu #HepatitisD (#HDV) und dem Medikament: https://www.klinikum.uni-heidelberg.de/newsroom/eine-chronische-krankheit-wird-therapierbar/

Artikel zum Gilead-Kauf:...
February 2, 2025 at 1:41 AM
contagionlive.bsky.social
nChroma Bio raises $75M to advance CRMA-1001, a liver-targeted epigenetic therapy for chronic hepatitis B and D, with clinical trials set for 2025. #HepatitisB #HepatitisD #MEDsky #IDsky
Read more: www.contagionlive.com/view/nchroma...
nChroma Bio Raises $75M to Advance Epigenetic Editing for Hepatitis B and D Cure
The development of CRMA-1001, a potential functional cure for chronic hepatitis B and D, is set to enter clinical trials in 2025.
www.contagionlive.com
December 13, 2024 at 6:57 PM
d-solve-consortium.bsky.social
🧬 D-SOLVE lecture via MS Teams:
Hepatitis D in Mongolia – Screening Study among Mongol Migrants in Sweden
👤 Speakers from Karolinska/Sweden & Mongolia
🗓️ Tue, 23 Sept | 🕐 12:45–13:30 CET
🔗 bit.ly/46oxjnH
🔑 ID: 368 532 223 585 | PW: dq64Nb9t
#DSOLVE #HepatitisD #PublicHealth
September 17, 2025 at 11:04 AM
4040rec.bsky.social
#Bluejay #BluejayTherapeutics #phase3trial #brelovitug #BJT778 #hepatitisD #AZURE2study #CHD #hepatitisDvirus #cirrhosis #livercancer #viralhepatitis #liverdisease #BreakthroughTherapydesignation #FDA #PRIMEdesignation #Orphanstatus #OrphanDrug #EMA
pharmatimes.com/news/bluejay...
Bluejay begins phase 3 trial of brelovitug for hepatitis D - PharmaTimes
First patient enrolled in AZURE-2 study comparing brelovitug to Hepcludex
pharmatimes.com
September 10, 2025 at 12:03 PM
melodieweller.bsky.social
New #Feed: #HDV #HepD #HepatitisD #HepatitisDVirus #HDV-like #Kolmioviridae #HepDVirus Tracking the latest in HDV and HDV-like viruses, from new publications to scientific breakthroughs and global events. Exploring virology, epidemiology, treatments, and diagnostics.

bsky.app/profile/did:...
March 2, 2025 at 12:07 PM
gastroagi.bsky.social
AASLD 2025 SOLSTICE Ph2: Tobevibart ± elebsiran in chronic #HepatitisD. Wk48 undetectable HDV RNA: 66% combo vs 48% mono; HBsAg <10 IU/mL: 91% vs 21%. Safe, well tolerated, no ALT flares. Promising dual HBV/HDV targeting.

🧠 gastroagi.com/chat
GastroAGI - AI Chat for Gastroenterology Students
Ask AI-powered questions about gastroenterology and enhance your academic learning.
gastroagi.com
January 13, 2026 at 7:05 AM
melodieweller.bsky.social
Anyone seeing reports of patients with #HepatitisD in the absence of #HepatitisB? My team is detecting #HDV antigens and RNA in salivary glands of #Sjogrens patients without evidence of #HBV. Thinking its more widespread. Current testing guidelines would miss. #ViroSky #LiverSky #GastroSky
April 4, 2025 at 11:13 AM
reibergerthomas.bsky.social
Treatment response to #Bulevirtide is linked to amelioration of #PortalHypertension in patients with chronic #HepatitisD

JHEP Reports
www.jhep-reports.eu/article/S258...
December 5, 2025 at 4:59 AM
europeliver.bsky.social
Let’s Talk Hepatitis D!
Many people living with Hepatitis D (HDV) remain undiagnosed—but early detection can change lives. 💪

🩺 Screening. Diagnosis. Therapy.
Early diagnosis is the key to managing HDV

#HepatitisD #LiverHealth #ScreenForLife #HepBShot #HepatitisAwareness #LinkToCare #WorldHepatitis
July 21, 2025 at 4:49 AM
ihieurope.bsky.social
🌍 On #WorldHepatitisDay, discover how our @viromarkers.bsky.social project is advancing markers to predict which patients will respond best to new #HepatitisD drug #bulevirtide.
👉 europa.eu/!FfGjJN
#hepatitis #IHITransformingHealth #HorizonEU
VIROMARKERS aims for revolution in care of people with persistent viral infections
The new project is advancing biomarkers that would improve the care of people living with HIV and hepatitis D, plus stem cell transplant patients at risk of cytomegalovirus (CMV).
europa.eu
July 28, 2025 at 9:37 AM
drrobertgish.bsky.social
Delta hepatitis (HDV) is deadly, neglected, and underfunded.

Our new article calls for HDV to be reclassified as an orphan disease—a key move to drive research, drug development & awareness. It’s time 🦠📣

🔗 journals.lww.com/hepcomm/page...
#HepatitisD #OrphanDisease #LiverHealth #GlobalHealth
A call to reclassify the delta hepatitis virus as an orphan ... : Hepatology Communications
An abstract is unavailable.
journals.lww.com
July 9, 2025 at 12:26 PM
d-solve-consortium.bsky.social
🎬 Just Released! 🌍 Dive into our latest #HDV-Awareness - campaign video featuring Dr. Lisa Sandmann & Dr. Helenie Kefalakes (both #HannoverMedicalSchool & #D-SOLVE). Discover the "Standard of Treatment in Germany and Worldwide". Watch now! youtu.be/d7dV2G6tMXA #HepatitisD #LiverHealth
youtu.be
April 2, 2025 at 7:55 AM
d-solve-consortium.bsky.social
Significant findings for our #D-SOLVE project: Scientists from #TWINCORE developed a stem cell-based model for the #HepatitisD virus, revealing the transcription factor IRF1 as a target for new treatments, also in association with Hepcludex. More info: twincore.de/news/better-...
Better insights into the hepatitis D virus
Hannover researchers develop stem cell-based infection model
twincore.de
April 28, 2025 at 10:40 AM
pharmaphorum.bsky.social
#HuahuiHealth has won the #firstapproval in #China for a drug to treat chronic infections with #hepatitisD virus (HDV), plugging a major gap in treatment options.
China clears its first drug for chronic hepatitis D
Huahui Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus.
buff.ly
January 27, 2026 at 5:30 PM
d-solve-consortium.bsky.social
📢 New Video! Join Prof. Wedemeyer (Hannover Medical School, #D-SOLVE) as he discusses the symptoms & consequences of untreated #HepatitisD. This video is part of our #Awareness campaign, highlighting the importance of early detection and treatment. Watch now and stay informed! youtu.be/BLnRhVehOlE
youtu.be
February 18, 2025 at 11:02 AM